Graeme Griffin

9.9k total citations · 3 hit papers
28 papers, 8.0k citations indexed

About

Graeme Griffin is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Toxicology. According to data from OpenAlex, Graeme Griffin has authored 28 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 16 papers in Cellular and Molecular Neuroscience and 7 papers in Toxicology. Recurrent topics in Graeme Griffin's work include Cannabis and Cannabinoid Research (22 papers), Neurotransmitter Receptor Influence on Behavior (13 papers) and Neuroscience and Neuropharmacology Research (10 papers). Graeme Griffin is often cited by papers focused on Cannabis and Cannabinoid Research (22 papers), Neurotransmitter Receptor Influence on Behavior (13 papers) and Neuroscience and Neuropharmacology Research (10 papers). Graeme Griffin collaborates with scholars based in United States, United Kingdom and Israel. Graeme Griffin's co-authors include Roger G. Pertwee, Lesley Stevenson, Raphael Mechoulam, Dan Gibson, Asher Mandelbaum, Aviva Breuer, William A. Devane, Billy R. Martin, Vincenzo Di Marzo and C. S. Breivogel and has published in prestigious journals such as Science, Cell Metabolism and Cancer Research.

In The Last Decade

Graeme Griffin

28 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

1992 4.5k citations Roger G. Pertwee, Lesley Stevenson et al. profile →
Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents

2006 539 citations Hilary A. Overton, S. M. Doel et al. Cell Metabolism profile →
Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity of Non–Small-Cell Lung Carcinoma Cell Lines and Xenografts to Epidermal Growth Factor Receptor Inhibition

2005 525 citations Filippo Petti, Graeme Griffin et al. profile →

Peers

Countries citing papers authored by Graeme Griffin

Since Specialization

Citations

This map shows the geographic impact of Graeme Griffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graeme Griffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graeme Griffin more than expected).

Fields of papers citing papers by Graeme Griffin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graeme Griffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graeme Griffin. The network helps show where Graeme Griffin may publish in the future.

Co-authorship network of co-authors of Graeme Griffin

This figure shows the co-authorship network connecting the top 25 collaborators of Graeme Griffin. A scholar is included among the top collaborators of Graeme Griffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graeme Griffin. Graeme Griffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents breakdown → 2006 ·Cell Metabolism ·Hilary A. Overton, (unknown), S. M. Doel, Matthew C. T. Fyfe, (unknown), Graeme Griffin, Helen C. Jackson, Martin J. Procter, Chrystelle M. Rasamison, Mads Tang‐Christensen, Peter Widdowson, (unknown), Christine Reynet	539
2	Phosphotyrosine Signaling Networks in Epidermal Growth Factor Receptor Overexpressing Squamous Carcinoma Cells 2005 ·Molecular & Cellular Proteomics ·(unknown), Filippo Petti, Graeme Griffin, Ken Iwata, (unknown), (unknown), David Fenyö, Neil W. Gibson, John D. Haley	119
3	A Structure/Activity Relationship Study on Arvanil, an Endocannabinoid and Vanilloid Hybrid 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Vincenzo Di Marzo, Graeme Griffin, Luciano De Petrocellis, (unknown), Tiziana Bisogno, William G. Williams, Mark C. Grier, (unknown), Anu Mahadevan, Raj K. Razdan, Billy R. Martin	74
4	Pharmacological Activity of Fatty Acid Amides Is Regulated, but Not Mediated, by Fatty Acid Amide Hydrolase in Vivo 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Aron H. Lichtman, Edward G. Hawkins, Graeme Griffin, Benjamin F. Cravatt	192
5	Paradoxical Pharmacological Effects of Deoxy-Tetrahydrocannabinol Analogs Lacking High CB<sub>1</sub> Receptor Affinity 2002 ·Pharmacology ·Jenny L. Wiley, (unknown), Graeme Griffin, John Liddle, Shu Yu, John W. Huffman, Billy R. Martin	13
6	SR-141716A-induced stimulation of locomotor activity 2002 ·Pharmacology Biochemistry and Behavior ·Caroline E. Bass, Graeme Griffin, Mark C. Grier, Anu Mahadevan, Raj K. Razdan, Billy R. Martin	40
7	Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain 2001 ·Molecular Pharmacology ·C. S. Breivogel, Graeme Griffin, Vincenzo Di Marzo, Billy R. Martin	14
8	Separation of cannabinoid receptor affinity and efficacy in delta‐8‐tetrahydrocannabinol side‐chain analogues 2001 ·British Journal of Pharmacology ·Graeme Griffin, (unknown), (unknown), Raj K. Razdan, Billy R. Martin, Mary E. Abood	9
9	Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding 2000 ·Drug and Alcohol Dependence ·(unknown), Graeme Griffin, John W. Huffman, Ming‐Jung Wu, (unknown), Bin Yang, Vincent M. Showalter, Mary E. Abood, Billy R. Martin	208
10	Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system 1999 ·European Journal of Pharmacology ·Graeme Griffin, (unknown), Tao Qing, Sean D. McAllister, (unknown), (unknown), Billy R. Martin, Mary E. Abood	121
11	Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum 1999 ·British Journal of Pharmacology ·Graeme Griffin, (unknown), Billy R. Martin, Mary E. Abood	11
12	An investigation into the structural determinants of cannabinoid receptor ligand efficacy 1999 ·British Journal of Pharmacology ·Graeme Griffin, (unknown), (unknown), Peter J. Crocker, William J. Ryan, Bijali Saha, Raj K. Razdan, Billy R. Martin, Mary E. Abood	23
13	Evaluation of Cannabinoid Receptor Agonists and Antagonists Using the Guanosine-5′-O-(3-[35S]thio)-triphosphate Binding Assay in Rat Cerebellar Membranes 1998 ·Journal of Pharmacology and Experimental Therapeutics ·Graeme Griffin, Peter J. Atkinson, Vincent M. Showalter, (unknown), Mary E. Abood	97
14	Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals 1997 ·European Journal of Pharmacology ·Graeme Griffin, Susanthi R. Fernando, Ruth A. Ross, Neil G. McKay, Michael L.J. Ashford, David Shire, John W. Huffman, Shu Yu, Julia A.H. Lainton, Roger G. Pertwee	144
15	Agonist-antagonist characterization of 6′-cyanohex-2′-yne-Δ8-tetrahydrocannabinol in two isolated tissue preparations 1996 ·European Journal of Pharmacology ·Roger G. Pertwee, Susanthi R. Fernando, Graeme Griffin, William J. Ryan, Raj K. Razdan, David M. Compton, Billy R. Martin	40
16	Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens 1995 ·European Journal of Pharmacology ·Roger G. Pertwee, Graeme Griffin, Julia A.H. Lainton, John W. Huffman	62
17	A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens 1995 ·European Journal of Pharmacology ·Roger G. Pertwee, Graeme Griffin	20
18	Effects of two endogenous fatty acid ethanolamides on mouse vasa deferentia 1994 ·European Journal of Pharmacology ·Roger G. Pertwee, Graeme Griffin, (unknown), Raphael Mechoulam	45
19	(R)-Methanandamide: A Chiral Novel Anandamide Possessing Higher Potency and Metabolic Stability 1994 ·Journal of Medicinal Chemistry ·Vasiliki Abadji, Sonyuan Lin, (unknown), Graeme Griffin, Lesley Stevenson, Roger G. Pertwee, (unknown)	299
20	Proton magnetic resonance spectra of tri-2-pyridylphosphine and the corresponding phosphine oxide and sulphide 1970 ·Journal of the Chemical Society B Physical Organic ·Graeme Griffin, W. A. Thomas	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact